HOXC-AS3
gene geneOn this page
Summary
HOXC-AS3 (HOXC cluster antisense RNA 3, HGNC:43751) is a long non-coding RNA gene on chromosome 12q13.13.
At a glance
- Gene type: non-coding (lncRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:43751 |
| Approved symbol | HOXC-AS3 |
| Name | HOXC cluster antisense RNA 3 |
| Location | 12q13.13 |
| Locus type | RNA, long non-coding |
| Status | Approved |
| Ensembl gene | ENSG00000251151 |
| Ensembl biotype | lncRNA |
| Entrez | 100874365 |
| RNAcentral | URS0000207271 — ncRNA, 368 nt, 2 organism(s) |
Gene structure
Transcript identifiers
Ensembl transcripts: 12 — 11 lncRNA, 1 retained_intron
ENST00000509870, ENST00000513165, ENST00000514702, ENST00000567780, ENST00000717839, ENST00000717840, ENST00000717841, ENST00000729786, ENST00000729787, ENST00000729788, ENST00000729789, ENST00000729790
RefSeq mRNA: 0 — MANE Select: None
Canonical transcript exons
ENST00000509870 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00004057688 | 53983185 | 53983864 |
| ENSE00004057696 | 53984710 | 53984838 |
Expression profiles
Bgee: expression breadth broad, 98 present calls, max score 80.09.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.1826 / max 12.0253, expressed in 84 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 131287 | 0.1171 | 52 |
| 131286 | 0.0655 | 31 |
Top tissues by expression
197 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| calcaneal tendon | UBERON:0003701 | 80.09 | gold quality |
| metanephros cortex | UBERON:0010533 | 75.88 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 71.41 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 70.64 | gold quality |
| muscle of leg | UBERON:0001383 | 70.39 | gold quality |
| cortex of kidney | UBERON:0001225 | 69.91 | gold quality |
| tibial artery | UBERON:0007610 | 69.88 | gold quality |
| popliteal artery | UBERON:0002250 | 69.86 | gold quality |
| gastrocnemius | UBERON:0001388 | 69.43 | gold quality |
| aorta | UBERON:0000947 | 67.84 | gold quality |
| skin of leg | UBERON:0001511 | 67.69 | gold quality |
| tendon | UBERON:0000043 | 66.31 | gold quality |
| metanephros | UBERON:0000081 | 65.42 | gold quality |
| skin of abdomen | UBERON:0001416 | 65.26 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 64.78 | gold quality |
| zone of skin | UBERON:0000014 | 63.51 | gold quality |
| kidney | UBERON:0002113 | 63.02 | gold quality |
| subcutaneous adipose tissue | UBERON:0002190 | 63.02 | gold quality |
| buccal mucosa cell | CL:0002336 | 58.10 | gold quality |
| sural nerve | UBERON:0015488 | 57.55 | silver quality |
| right ovary | UBERON:0002118 | 56.19 | gold quality |
| left uterine tube | UBERON:0001303 | 55.75 | gold quality |
| adipose tissue | UBERON:0001013 | 54.94 | gold quality |
| parotid gland | UBERON:0001831 | 53.22 | gold quality |
| anatomical system | UBERON:0000467 | 51.78 | gold quality |
| multicellular organism | UBERON:0000468 | 51.36 | gold quality |
| material anatomical entity | UBERON:0000465 | 51.33 | gold quality |
| lymph node | UBERON:0000029 | 50.34 | gold quality |
| monocyte | CL:0000576 | 49.71 | silver quality |
| left ovary | UBERON:0002119 | 49.29 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.64 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 8)
- YBX1 participates in HOXC-AS3-mediated gene transcriptional regulation in the tumorigenesis of gastric cancer. (PMID:30286788)
- HOXC-AS3 is aberrantly overexpressed in breast cancers especially the HER2+ type. High expression of HOXC-AS3 has a relationship with poor clinical outcomes of breast cancer. HOXC-AS3 regulates cell invasion and migration both in vitro and in vivo. Results demonstrated that miR-3922-5p was a direct target of HOXC-AS3, and PPP1R1A was a target of miR-3922-5p in breast cancer. (PMID:31797701)
- Long noncoding RNA HOXC-AS3 facilitates the progression of invasive mucinous adenocarcinomas of the lung via modulating FUS/FOXM1. (PMID:31925650)
- Long noncoding RNA HOXC-AS3 enhances the progression of cervical cancer via activating ErbB signaling pathway. (PMID:34387789)
- Low Glucose-Induced Overexpression of HOXC-AS3 Promotes Metabolic Reprogramming of Breast Cancer. (PMID:35031573)
- LncRNA HOXC-AS3 promotes non-small-cell lung cancer growth and metastasis through upregulation of YBX1. (PMID:35387975)
- LncRNA HOXC-AS3 overexpression inhibits TGF-beta2-induced colorectal cancer cell migration and invasion by sponging miR-1269. (PMID:35537198)
- LncRNA HOXC-AS3 accelerates malignant proliferation of cervical cancer cells via stabilizing KDM5B. (PMID:38842683)
Cross-species orthologs
0 orthologs
Protein
Non-coding RNA — no protein product; not a drug target.
Function
No curated pathway, Gene-Ontology, or interaction data.
Disease & clinical
No curated disease, variant, or cancer-driver associations.
Drugs & pharmacology
No drug or pharmacology data — not an established drug target.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.